Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.

@article{Hoskins2008CarboplatinPP,
  title={Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.},
  author={Paul J Hoskins and Nhu Tuyen Le and Susan L Ellard and Ursula E Lee and Lee Ann Martin and Kenneth D. Swenerton and Anna V. Tinker},
  journal={Gynecologic oncology},
  year={2008},
  volume={108 1},
  pages={58-62}
}
OBJECTIVES Uterine MMMTs are aggressive malignancies that are rarely cured by purely local therapies. Effective chemotherapy is needed. The phase III proven, ifosfamide-based combinations are inconvenient and costly. Carboplatin and paclitaxel (CT) are easy to deliver and is effective against endometrial carcinoma and should be against MMMT (as they are now regarded as epithelial in nature). METHODS A review of all women with uterine MMMT treated with CT. Paclitaxel 175 mg/m2 over 3 h… CONTINUE READING
18 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…